Parkinson's Disease

Parkinson's Disease

Challenges and good outcomes with telemedicine during COVID-19 2:27
Challenges and good outcomes with telemedicine during COVID-19
Alfonso Fasano • 16 Sep 2020
Research in Parkinson’s disease: lysosomal dysfunction, immune response and antibodies 3:41
Research in Parkinson’s disease: lysosomal dysfunction, immune response and antibodies
Tiago Outeiro • 18 Sep 2020
The advancements in treatment and management for Parkinson’s disease 1:38
The advancements in treatment and management for Parkinson’s disease
Charles H. Adler • 10 Sep 2020
The challenge of diagnosing heterogeneous movement disorders 2:16
The challenge of diagnosing heterogeneous movement disorders
Cynthia Comella • 17 Sep 2020
Developments in Parkinson’s disease research and PASADENA clinical trial update 3:21
Developments in Parkinson’s disease research and PASADENA clinical trial update
Tiago Outeiro • 18 Sep 2020
Peripheral α-synuclein as a Parkinson’s disease biomarker 4:00
Peripheral α-synuclein as a Parkinson’s disease biomarker
Charles H. Adler • 10 Sep 2020
Dystonia, ataxia and tics in movement disorders 1:09
Dystonia, ataxia and tics in movement disorders
Cynthia Comella • 17 Sep 2020
The importance of longitudinal COVID-19 studies and the potential of ASOs 2:30
The importance of longitudinal COVID-19 studies and the potential of ASOs
Tiago Outeiro • 18 Sep 2020
Remedial electrode placement in deep brain stimulation and speech impairments 2:15
Remedial electrode placement in deep brain stimulation and speech impairments
Terry Ellis • 14 Sep 2020
Potential of RT-QuIC for Parkinson’s diagnosis 0:46
Potential of RT-QuIC for Parkinson’s diagnosis
Charles H. Adler • 10 Sep 2020
Recent developments in diagnosing and treating dystonia 2:45
Recent developments in diagnosing and treating dystonia
Cynthia Comella • 17 Sep 2020
Complications with Parkinson’s disease and COVID-19 3:05
Complications with Parkinson’s disease and COVID-19
Alfonso Fasano • 16 Sep 2020
Controversial: early administration of deep brain stimulation in Parkinson’s disease 1:29
Controversial: early administration of deep brain stimulation in Parkinson’s disease
Jens Volkmann • 16 Sep 2020
The role of inflammation in Parkinson’s disease and an avenue for potential treatment 1:29
The role of inflammation in Parkinson’s disease and an avenue for potential treatment
Malú Tansey • 15 Sep 2020
Spasticity and ataxia: lack of available treatment and the importance of rehabilitation 2:05
Spasticity and ataxia: lack of available treatment and the importance of rehabilitation
Carlos Henrique Camargo • 7 Sep 2020
Potential pharmacological candidates targeting inflammation in Parkinson’s disease 3:13
Potential pharmacological candidates targeting inflammation in Parkinson’s disease
Malú Tansey • 15 Sep 2020
The content of VJNeurology is intended for healthcare professionals